Literature DB >> 24931838

The abandoned controversy surrounding universal white blood cell reduction.

Eleftherios C Vamvakas1.   

Abstract

Mesh：

Year:  2014        PMID： 24931838      PMCID： PMC4039693          DOI： 10.2450/2014.0009-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  19 in total

1.  The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial.

Authors:  Avery B Nathens; Theresa A Nester; Gordon D Rubenfeld; Raminder Nirula; Terry B Gernsheimer
Journal:  Shock       Date:  2006-10       Impact factor: 3.454

2.  White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta-analysis.

Authors:  E C Vamvakas
Journal:  Vox Sang       Date:  2007-04       Impact factor: 2.144

Review 3.  Transfusion-related immunomodulation: a second hit in an inflammatory cascade?

Authors:  Y M Bilgin; A Brand
Journal:  Vox Sang       Date:  2008-11       Impact factor: 2.144

Review 4.  Transfusion-related immunomodulation (TRIM): an update.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Blood Rev       Date:  2007-09-04       Impact factor: 8.250

5.  Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions.

Authors:  Argirios E Tsantes; Elias Kyriakou; Georgios K Nikolopoulos; Dimitrios Stylos; Marlene Sidhom; Stefanos Bonovas; Panagiota Douramani; Dimitrios Kalantzis; Styliani Kokoris; Serena Valsami; Konstantinos Stamoulis; Marianna Politou; Leontini Foudoulaki-Paparizos
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

6.  Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study.

Authors:  I L Titlestad; L S Ebbesen; A P Ainsworth; S T Lillevang; N Qvist; J Georgsen
Journal:  Int J Colorectal Dis       Date:  2001-06       Impact factor: 2.571

7.  Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery.

Authors:  L S Jensen; A J Andersen; P M Christiansen; P Hokland; C O Juhl; G Madsen; J Mortensen; C Møller-Nielsen; F Hanberg-Sørensen; M Hokland
Journal:  Br J Surg       Date:  1992-06       Impact factor: 6.939

Review 8.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

9.  Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery.

Authors:  Y M Bilgin; L M G van de Watering; L Eijsman; M I M Versteegh; R Brand; M H J van Oers; A Brand
Journal:  Circulation       Date:  2004-05-17       Impact factor: 29.690

10.  Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery.

Authors:  P I Tartter; K Mohandas; P Azar; J Endres; J Kaplan; M Spivack
Journal:  Am J Surg       Date:  1998-11       Impact factor: 2.565
View more
  3 in total

Review 1.  Leucoreduction of blood components: an effective way to increase blood safety?

Authors:  Maria Bianchi; Stefania Vaglio; Simonetta Pupella; Giuseppe Marano; Giuseppina Facco; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

2.  A Novel Centrifugation Method Using a Cell Salvage Device Offers an Alternative to the Use of Leukocyte-Depleting Filters for Autologous Blood Transfusions.

Authors:  Michael Barchilon; Cristina Gaspar; Angela Mexas; Don Nieter
Journal:  J Extra Corpor Technol       Date:  2016-12

Review 3.  Improving platelet transfusion safety: biomedical and technical considerations.

Authors:  Olivier Garraud; Fabrice Cognasse; Jean-Daniel Tissot; Patricia Chavarin; Syria Laperche; Pascal Morel; Jean-Jacques Lefrère; Bruno Pozzetto; Miguel Lozano; Neil Blumberg; Jean-Claude Osselaer
Journal:  Blood Transfus       Date:  2015-11-16       Impact factor: 3.443
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.